The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

NCT02129179 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER_GOV

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Glucagon-Like Peptide 1

Sponsor

Papworth Hospital NHS Foundation Trust